2025 Q4
2025-11-26
Designation of Certain Members of Management as Executive Officers and Resignation of Lindsay D. Hans, Kathleen A. Knox, Matthew M. Koder, and Eric A. Schimpf
Effective December 31, 2025
View Filing →
2025-10-16
Legal Opinion Filing
Legal opinion filed for Series P Notes and Series A Notes under existing S-3 shelf registration
View Filing →
2025 Q3
2025-09-15
Co-Presidents Appointed
Dean Athanasia & James DeMare named Co-Presidents, Borthwick promoted to EVP
View Filing →
2025-09-12
Executive Appointments - Co-Presidents Named
Dean Athanasia and James DeMare appointed Co-Presidents, Alastair Borthwick named EVP
View Filing →
2025-07-24
Preferred Stock Offering
2.5M depositary shares, 6.25% Series UU preferred stock, $25K liquidation preference
View Filing →
2025-07-23
Stock Buyback & Dividend
$40B buyback program, $0.28 quarterly dividend
View Filing →
2025-07-16
Q2 2025 Earnings
Net income $7.1B, EPS $0.89
View Filing →
2025-07-01
Dividend Increase & CCAR Results
Dividend up to $0.28/share, CET1 ratio 11.8%
View Filing →
2025 Q2
2025-04-29
Preferred Stock Offering
3M depositary shares, Series OO 6.625% preferred stock
View Filing →
2025-04-24
Annual Shareholder Meeting
Equity plan amended: +100M shares, director comp capped at $1M annually
View Filing →
2025-04-15
Q1 2025 Earnings
Net income $7.4B, EPS $0.90
View Filing →
2025 Q1
2025-02-28
Chief Accounting Officer Change
Johnbull Okpara appointed CAO, $600K salary + $5.4M incentive
View Filing →
2025-02-07
CEO Compensation Approved
Moynihan 2024 total comp $35M vs $29M in 2023
View Filing →
2025-01-29
Director Appointed
Maria N. Martinez appointed to Board and committees
View Filing →
2025-01-16
Q4 2024 Earnings
Q4 net income $6.7B, EPS $0.82; FY net income $27.1B, EPS $3.21
View Filing →